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Abstract
Background: Computed tomography (CT) imaging has improved the chances of detecting small indeterminate 
(<1 cm) lung nodules. The determination of the underlying malignant or benign nature of a lung nodule poses a 
great diagnostic challenge and depends on a number of factors, including the radiographic appearance of nodule, the 
presence of non-pulmonary metastases, characteristics of growth and histological criteria.
Methods: The medical records of 89 patients admitted to our specialist cancer centre between 2008 and 2013 were 
reviewed. Patients of all age groups and tumour category were included in the study. Clinical data of these patients were 
collected and the following parameters were analysed: Radiographic diagnosis, location, size, laterality and number of 
nodules and histological impression. The radiological findings were then correlated with histopathological findings. 
The nodules were sub-classified into groups on the basis of size (A = 0–0.5 cm; B = 0.5–0.9 cm; C = 1.0–1.5 cm and 
D = >1.5 cm). 
Results: CT scan reports of 89 patients with lung nodules were reviewed. On radiology, 73/89 (82%) were 
reported to be malignant nodule. Histopathological review of the biopsies of these 89 nodules confirmed 
malignancy in 50/89 (56.2%) patients. CT scan was found to be highly sensitive (94%, 95% confidence interval 
[CI]: 83.43–98.68%) but with a very low specificity (33.3%, 95% CI: 19.10–50.22%). CT scan was found to 
have a higher negative predictive value (81.2%, 95% CI: 54.34–95.73%) and a lower positive predictive value 
64.4% (95% CI: 52.31–75.25%) when correlated with histopathological findings. Pathology of these nodules 
included metastatic sarcoma (27/89; 30.3%) and carcinoma (18/89; 20.2%). The frequency of the biopsy-proven 
malignant nodules on the right side was 26/45 (57.8%) and on the left side was 24/44 (54.5%) (P = 0.832). 
Malignant nodules were more frequent in lower lobes (28/43, 65.1%) than in upper lobes (14/32, 43.8%). These 
two sites combined accounted for 84% of all malignant nodules. There was a significant correlation between 
nodule size and likelihood of underlying malignancy. The overall prevalence of malignancy in the larger nodules 
(C and D) was much higher (23/30 and 76.7%) compared to the smaller sized (A and B) nodules (27/58 and 
46.8%), P < 0.05.
Conclusion: CT scan is a useful tool in the initial clinical assessment of indeterminate lung nodules with high 
sensitivity (94%) and a high negative predictive value (81.2%).
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The lung is the most common site for metastasis. The 
common tumours which metastasise to the lung include 
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renal, breast, colon and prostate carcinomas as well as 
sarcomas. Lung nodules are small, focal and radiographic 
opacities that can be either single or multiple. Nodules 
>3 cm are called lung masses and can be diagnosed 
easily on chest X-ray. However, small nodules (<1 cm), 
diagnosed only on high resolution computed tomography 
(CT) scan, are called indeterminate lung nodules. Recent 
advances in CT imaging have dramatically improved the 
chances of detecting indeterminate lung nodules.
Determination of small indeterminate lung nodule, 
or multiple nodules, during the initial evaluation 
and staging of tumour in a patient, offers a great 
diagnostic challenge. Malignant or benign nature of 
pulmonary nodule will affect the treatment plan and 
the eligibility of the patient for treatment protocols and 
disease prognosis. The determination or presumption 
of pulmonary metastasis depends on multiple factors 
such as radiographic appearance of nodule, presence 
of evidence of non-pulmonary metastasis, growth 
characteristics and histological evaluation of biopsy. 
Nevertheless, radiology alone cannot determine the 
disease status of a nodule.[1-3]
The detection of a solitary pulmonary nodule in healthy 
adults during evaluation for screening purpose advocates 
the reliance on growth kinetics.[4,5] The advent of refined 
CT imaging, particularly helical CT and the ability to 
obtain thinner axial sections has dramatically increased the 
detection of pulmonary nodules.[6] Second, evaluation by 
the picture archive communications system (PACS) allows 
better enlargement of individual images and less loss of 
resolution as compared to traditional film images. These 
advances in radiological techniques allow the detection 
of small indeterminate nodules that would otherwise have 
not been possible with the use of plain X-ray technique, 
thus increasing the likelihood of a CT detected nodule to 
be malignant.[7-9]
To address the challenging question that CT detected 
lung nodule is more likely to be malignant, the medical 
records and relevant CT scans of children and adults who 
had been referred to our institution for the evaluation 
of indeterminate lung nodules and lung metastasis 
were reviewed. The patients’ clinical or radiographic 
characteristics were correlated with histologic features of 
nodules and disease stage. Most of the nodules diagnosed 
as malignant on radiology turned out to be benign, 
proving that histological correlation is an important tool in 
conjunction with CT scan for confirmation of malignancy 
in suspicious lung nodules.
Methods
The clinical data of patients with indeterminate lung 
nodules detected on a CT scan and referred to Shaukat 
Khanum Memorial Cancer Hospital and Research 
Centre (SKMCH and RC), Lahore, Pakistan between 
1 January, 2008, and 30 June, 2013, were reviewed. 
Patients referred for consultation only, and for whom no 
chest CT was available, were excluded from the study. 
CT scans showing inflammatory infiltrate or atelectasis 
were also excluded from our study. Chest CT scans with 
potential nodules and masses were then reviewed by a 
single radiologist using PACS to determine the exact 
number of nodules, the size of the largest nodule or mass, 
laterality, the pattern of distribution of the nodules and 
presence of calcifications since calcification can be seen 
within nodules in case of metastatic osteosarcoma and 
granulomatous disease. Pulmonary nodules were defined 
as any round abnormal lung opacities measuring ≤3 cm. 
Lung masses were defined as abnormal, round lung 
opacities measuring >3 cm in any dimension.[10,11] The CT 
lung nodules were then divided into four groups: Group A 
with nodules of 5 mm or less; Group B with nodules 
between 5 and 9 mm; Group C with nodules between 
10 and 15 mm and Group D with nodules of >15 mm. 
These findings were then correlated with histology. Data 
were compared using cross-tabulation and associations 
among factors were examined using the Fischer exact 
test, χ2 test, Wilcoxon rank sum test or Kruskal–Wallis 
test as appropriate. Exact statistical tests were used when 
sample sizes were small. No adjustments were made for 
multiple comparisons in this exploratory study. P < 0.05 
was considered to be statistically significant. This study 
was approved by the Institutional Review Board of 
SKMCH and RC.
Results
During the study period, a total of 89 patients with lung 
nodules on CT scan underwent lung biopsies. The biopsy 
results were correlated with the radiological size of lung 
nodules including the indeterminate nodules diagnosed 
on radiology. On radiological impression, a majority 
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of these patients (73/89 and 82.0%) were reported to 
have a malignant nodule. In another six patients (6.7%), 
a diagnosis of benign tumour was made, whilst eight 
patients (9.0%) were considered to have indeterminate 
nodules. Two patients (2.2%) with previous follow-up on 
nodules were reported to have stable nodules. 44 (49.4%) 
were on the left side while right-sided nodules were seen 
in 45 (50.6%) patients. There was no statistical difference 
in the laterality of the malignant nodules (right = 38/45, 
84.4% and left = 35/44, 79.5%; P = 0.547). The relative 
frequency of nodules was higher in the lower lobes 
(n = 43 and 48.3%) than in the upper lobes (n = 32 and 
36.0%). The remainder of the nodules were reported in 
the apex (1.1%), diaphragm (1.1%), middle lobe (10.1%) 
and diffuse/whole lung (2.2%). A majority of the nodules 
fell in category B (31/89; 34.8%) followed by A (21/89, 
30.3%), D (21/89, 23.6%) and C (9/89, 10.1%). Table 1 
shows the baseline characteristics of lung nodules on 
radiology in 89 patients.
Histopathological review of the biopsies on these 89 
nodules revealed malignancy in 50 (56.2%) of the patients. 
The CT scan was found to be highly sensitive (94%, 95% 
confidence interval [CI]: 83.43–98.68%) but with very 
low specificity (33.3%, 95% CI: 19.10–50.22%). The 
positive predictive value of CT scan, when correlated 
with histopathological findings, was 64.4% (95% 
CI: 52.31–75.25%) with a high negative predictive value 
of 81.2%.
All 50 cases of biopsy-proven malignant nodules were 
equally likely to have nodules in the right (26/50; 52.0%) 
or left (24/50; 48.0%) lung (P = 0.832). A majority of the 
malignant nodules were seen in the lower lobe (28/50, 
56.0%) and upper lobe (14/50, 28.0%). These two sites 
combined accounted for 84.0% of all the malignant 
nodules seen.
There was, however, a significant correlation between 
nodule size and likelihood of underlying malignancy. 
The proportion of malignant cases based on size in the 
order of decreasing percentage was C (7/9; 77.8%); 
D (16/21, 76.2%), A (14/27; 52.8%) and B (13/31; 41.9%), 
P < 0.027.
The overall prevalence of malignancy in the larger nodules 
(C, D) was much higher (23/30; 76.7%) compared to the 
smaller (A, B) nodules (26/58; 44.8%). The proportion of 
malignancy in nodules increased with increasing number 
of the nodules (3>2>1). However, overall malignancy 
rates were lowest in patients with multiple lung nodules. 
The presence of 1, 2 and 3 nodules on CT scan was 
associated with 66%, 69% and 83% risk of malignancy. 
Table 2 provides details of malignant nodules with 
increasing number.
Histopathology reports of the lung biopsies showed 





Lower lobe 43/89 (48.3)
Upper lobe 32/89 (36.0)





Category A (≤5 mm) 27/89 (30.3)
Category B (5≤9 mm) 31/89 (348)
Category C (10≤15 mm) 9/89 (10.1)


















Multiple (>3) 27 23
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commonly reported diagnoses were sarcoma (27/89; 
30.3%) and carcinoma (18/89; 20.2%). The less commonly 
reported tumours and diagnoses are shown in Table 3. 
39/89 (43.8%) nodules were found to be benign on 
histopathological evaluation. The most common benign 
histological diagnoses were fibrosis (7/39; 17.9%), 
followed by necrosis (7/39; 17.9%), silicosis (4/39; 10.3%), 
haematoma (4/39; 10.3%), benign not otherwise classified 
(4/39; 10.3%), granuloma (3/39; 7.7%), lymph node (2/39; 
5.1%), debris (2/39, 5.1%), anthracotic nodule (2/39; 
5.1%), calcification (1/39, 2.6%), non-specific interstitial 
pneumonitis (1/39; 2.6%), hamartoma (1/39; 2.6%) and 
benign lung tissue (1/39; 2.6%). These characteristics of 
benign nodules are described in Tables 4 and 5.
Discussion
In this case series of 89 patients with radiographic findings 
of lung nodules, malignancy was found in a majority of 
the patients. CT scan was found to be highly sensitive in 
detecting small indeterminate nodules (94%) in patients. 
However, the positive predictive value of CT scan was 
only 64%, due to poor discrimination between benign and 
malignant nodules on CT scan. Another feature associated 
with the prediction of malignancy on CT scan-detected 
lung nodules was the size of the lung nodule. Given the 
low positive predictive value, all cases of indeterminate 
lung nodule should be correlated with biopsy and 
histopathology.
The majority (56.2%) of patients with lung nodules in 
this study had pulmonary metastatic disease, based on 











Silicotic nodule 4 (4.5)
Anthracotic nodule 2 (2.2)
Necrotic debris 2 (2.2)
Germ cell tumour 2 (2.2)




Non‑specific interstitial Pneumonitis 2 (2.2)
Lung tissue 1 (1.1)
Wilms’ tumour 1 (1.1)
Table 4: Correlation between histopathology and radiographic findings of benign nodules
Histopathology finding Radiographic finding
Benign Malignant Suspicious Total
Fibrosis 1 5 1 7
Calcification 0 1 0 1
Debris 1 1 0 2
Necrosis 0 3 0 7
Non‑specific interstitial pneumonitis 1 0 4 1
Lymph node 0 0 0 2
Hamartoma 0 1 2 1
Silicotic nodule 1 3 0 4
Lung tissue 1 0 0 1
Anthracotic nodule 0 2 0 2
Haematoma 0 4 0 4
Benign 0 3 1 4
Granuloma 0 3 0 3
Total 5 26 8 39
JOURNAL OF CANCER & ALLIED SPECIALTIES 5
ORIGINAL ARTICLE J Cancer Allied Spec 2015;1(1):3
pulmonary metastasis in our study group is higher than 
reported in previous studies of patients with bone and 
soft tissue sarcomas from other institutions around the 
world where it ranges from 15 to 26%.[12-15] This is likely 
because we selected cases that had a previous history of 
malignancy and we reviewed only those cases where lung 
nodules had been detected on CT scan and the patients 
had a histopathological analysis of lung tissue biopsies.
The radiographic characteristics of pulmonary nodules 
were evaluated using new technologic advances in 
CT imaging which allowed us to detect multiple small 
nodules, which would not have been detected otherwise, 
if older CT techniques had been used. The clinical 
significance of detecting small pulmonary metastatic 
lesions has been controversial. Several studies of Wilm’s 
tumour documents nodules detected by CT scan which 
were not visible on chest X-ray. The effect of this finding 
on disease prognosis was not consistent.[3,16,17]
Several research studies have been done to determine the 
prognostic significance of the pattern of distribution of 
metastatic lung nodules in large groups of patients. The 
results have been variable. However, none of these studies 
evaluated the size of the lesions.[18-24] The Mayo Clinic 
CT screening trial showed that 0% of nodules measuring 
<4 mm and 0.8% lung nodules measuring between 4 and 
7 mm in diameter were malignant. Another study reported 
0% of nodules measuring <5 mm in diameter were 
malignant, whilst the rate was 5.9% for those measuring 
5–9 mm in diameter.[25,26] The results of these studies are 
in contrast to our results since in our study 51.8% and 
31.8% of category A and B nodules showed malignancy, 
respectively.
Analysis of our research data also indicated that increasing 
numbers of nodules are associated with an increased risk 
of malignancy. The presence of 1, 2 and 3 nodules on 
CT scan was associated with 66%, 69% and 83% risk of 
malignancy. The risk of malignancy with an increasing 
number of nodules is relatively high in our study. Most 
of the cases with diffuse and bilateral lung nodularity, 
however, were found to have a benign granulomatous 
process. This could be explained by the fact that 
tuberculosis, which is a leading cause of this kind of 
benign granulomatous process, is endemic in Pakistan.
In addition, the risk of malignancy was also higher in 
larger nodules compared to smaller nodules. This suggests 
that risk assignment of lung nodules should be based on 
the number as well as the size of lung nodules. We did not 
find any association between laterality and distribution of 
the lung nodules.
Our study had several limitations. First, we relied on a 
relatively small sample size from a single institution. 
Second, the assessment of CT scans was carried out by a 
single investigator. Third, there is a possibility of sampling 
errors during a biopsy or attempted resection of pulmonary 
nodules. This could have been reduced by the use of CT-
guided needle localisation of a suspicious nodule, but our 
analyses did not allow us to determine if this technique 
was used in a systematic manner.
Conclusion
The classification of indeterminate lung nodules on 
radiology as malignant or benign depends on a number 
of factors including their size, laterality, site in the lung 
and the number of nodules present. We found a significant 
association of malignancy with larger nodules and an 
increasing number of nodules. CT scan is a useful tool 
in the initial clinical assessment of these indeterminate 
lung nodules and has a high sensitivity of detecting small 
nodules, with a high negative predictive value, but does 
require correlation with clinical and histopathological 
data.
Table 5: Correlation of size of the nodule with histopathological diagnosis
Radiological size of nodule Total number of nodules Biopsy proven malignant Biopsy proven benign
Group A (size 0–5 mm) 27 14 13
Group B (size 5–9 mm) 31 12 19
Group C (size 10–15 mm) 9 7 2
Group D (size > 15 mm) 21 16 5
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